Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide

被引：0
|
作者：
M. Niemi
J. T. Backman
M. Neuvonen
P. J. Neuvonen
机构：
[1] Helsinki University Central Hospital,Department of Clinical Pharmacology
来源：
Diabetologia | 2003年 / 46卷
关键词：
CYP2C8; CYP3A4; drug interaction; gemfibrozil; hypoglycaemia; itraconazole; repaglinide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：347 / 351
页数：4
相关论文
共 30 条
  • [1] Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide
    Niemi, M
    Backman, JT
    Neuvonen, M
    Neuvonen, PJ
    DIABETOLOGIA, 2003, 46 (03) : 347 - 351
  • [2] Repaglinide and gemfibrozil interaction: serious hypoglycemia
    Wooltorton, E
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2003, 169 (08) : 813 - 813
  • [3] Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone
    Jaakkola, T
    Backman, JT
    Neuvonen, M
    Neuvonen, PJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (05) : 404 - 414
  • [4] Repaglinide/gemfibrozil interaction may lead to severe hypoglycaemia
    Reactions Weekly, 2003, 973 (1) : 2 - 2
  • [5] Repaglinide-gemfibrozil drug interaction: inhibition of repaglinide glucuronidation as a potential additional contributing mechanism
    Gan, Jinping
    Chen, Weiqi
    Shen, Hong
    Gao, Ling
    Hong, Yang
    Tian, Yuan
    Li, Wenying
    Zhang, Yueping
    Tang, Yuwei
    Zhang, Hongjian
    Humphreys, William Griffith
    Rodrigues, A. David
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 (06) : 870 - 880
  • [6] THE EFFECT OF GEMFIBROZIL ON REPAGLINIDE PHARMACOKINETICS PERSISTS FOR AT LEAST 12 H POSTDOSE
    Tornio, Aleksi
    Niemi, Mikko
    Neuvonen, Mikko
    Laitila, Jouko
    Kalliokoski, Annikka
    Neuvonen, Pertti J.
    Backman, Janne T.
    DRUG METABOLISM REVIEWS, 2008, 40 : 77 - 78
  • [7] EXPLORING THE DRUG-DRUG INTERACTION BETWEEN GEMFIBROZIL AND REPAGLINIDE IN RATS: METABOLISM AND TRANSPORT
    Barbara, Joanna E.
    Muranjan, Seema
    Stanley, Forrest
    Kollu, Chandra
    Kandel, Sylvie
    Otwell, Clayton
    Buckley, David B.
    DRUG METABOLISM REVIEWS, 2015, 47 : 120 - 120
  • [8] Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism
    Kalliokoski, A.
    Backman, J. T.
    Kurkinen, K. J.
    Neuvonen, P. J.
    Niemi, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (04) : 488 - 496
  • [9] FURTHER EXPLORATION INTO THE DRUG-DRUG INTERACTION BETWEEN GEMFIBROZIL AND REPAGLINIDE IN RATS: UPTAKE TRANSPORT
    Mccoy, Chase I.
    Stanley, Forrest A.
    Kollu, Chandra
    Muranjan, Seema
    Green, Krystal M.
    Barbara, Joanna E.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S49 - S50
  • [10] Dose-Dependent Interaction between Gemfibrozil and Repaglinide in Humans: Strong Inhibition of CYP2C8 with Subtherapeutic Gemfibrozil Doses
    Honkalammi, Johanna
    Niemi, Mikko
    Neuvonen, Pertti J.
    Backman, Janne T.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (10) : 1977 - 1986
123